Saturday 17 October 2026
Export LUCD’s income statement to Excel — free account
Lucid Diagnostics Inc.
LUCD Healthcare Medical Devices
Lucid Diagnostics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 million, up 8.28% from fiscal 2024. In the quarter to June 2026, revenue grew 26.7%, EPS was flat, free cash flow fell 7.04% and total debt fell 7.11%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
0.48
0.04
−7.69%
Follow LUCD
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Piotroski F-Score |
4 | 5 | 4 | — | — | — | — | — | — |
P/S ratio |
23.61 | 9.53 | 23.90 | 74.27 | 0.00 | — | — | — | — |
Altman Z-Score |
(10.91) | (13.05) | (12.64) | (6.21) | 12.63 | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(28.53) | (31.13) | (31.81) | (15.69) | 13.95 | — | — | — | — |
P/Operating CF |
(8.83) | (4.20) | (5.82) | (11.81) | (10.11) | — | — | — | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 2.18 | 1.83 | — | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 2.57 | 1.83 | — | — | — | — |
EV/Sales |
21.34 | 8.67 | 21.87 | 42.49 | 0.00 | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
EV/Operating CF |
(2.16) | (0.85) | (1.62) | (0.97) | (3.89) | — | — | — | — |
EV/FCF |
(2.15) | (0.85) | (1.61) | (0.94) | (3.70) | — | — | — | — |
Quick Ratio |
1.24 | 0.95 | 0.64 | 2.67 | 12.64 | 0.01 | 0.02 | 0.02 | — |
Current Ratio |
1.31 | 1.07 | 0.75 | 2.89 | 13.45 | 0.09 | 0.06 | 0.02 | — |
Net Debt/EBITDA |
0.22 | 0.08 | 0.11 | 0.40 | 1.96 | 0.01 | 0.04 | 0.02 | — |
Debt/Assets |
59.34% | 60.56% | 51.16% | 2.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
2.19 | 3.45 | (6.04) | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.13 | 0.15 | 0.08 | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.66 | 0.83 | 0.62 | 0.53 | 0.63 | 0.68 | 0.53 | 0.10 | — |
Capex/Depreciation |
(0.23) | (0.55) | (0.09) | (0.47) | (215.50) | — | — | — | — |
Interest Coverage |
(2,256.36) | (1,771.23) | (116.54) | (7,031.37) | (41.61) | — | — | — | — |
| 152.80% | 151.58% | (4,989.67%) | (144.42%) | (136.23%) | 87.96% | 138.75% | 35.34% | — | |
| (198.34%) | (182.89%) | (176.20%) | (122.77%) | (91.77%) | (512.87%) | (840.64%) | (12,650.56%) | — | |
ROIC |
(13,430.74%) | (1,762.55%) | 0.00% | (2,290.35%) | (1,582.35%) | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(727.89%) | (1,974.13%) | 881.44% | (320.56%) | (51.98%) | 58.01% | 74.27% | 105.95% | — |
Average Days of Receivables |
49.87 | 3.78 | 6.76 | 16.46 | 146.00 | — | — | — | — |
Research and Development Expense of Revenue |
120.65% | 137.87% | 298.68% | 2,985.94% | 1,859.20% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
883.49% | 842.59% | 1,468.62% | 10,638.73% | 3,607.60% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.01 | 0.02 | 0.05 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
95.43% | 104.33% | 280.97% | 3,976.39% | 1,919.80% | 0.00% | — | — | — |
Graham Net Nets |
0.07 | 0.00 | (0.13) | 0.30 | 0.53 | — | — | — | — |
Graham Number |
3.03 | 4.86 | 3.79 | 0.00 | 0.00 | — | — | — | — |
Earnings Yield |
(88.07%) | (131.71%) | (91.37%) | (111.55%) | (28.03%) | — | — | — | — |
Free Cash Flow Yield |
(42.01%) | (107.27%) | (56.92%) | (60.85%) | (18.55%) | — | — | — | — |
Revenue per Share |
0.05 | 0.09 | 0.06 | 0.01 | 0.03 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(0.46) | (0.87) | (0.79) | (0.82) | (0.95) | (0.40) | (0.06) | 0.00 | — |
Capex per Share |
0.00 | (0.01) | (0.01) | (0.03) | (0.05) | 0.00 | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(0.46) | (0.89) | (0.79) | (0.85) | (1.00) | (0.40) | (0.06) | 0.00 | — |
Cash per Share |
0.34 | 0.44 | 0.45 | 0.62 | 2.88 | 0.01 | 0.00 | 0.00 | — |
Shareholders Equity per Share |
0.11 | 0.11 | (0.06) | 0.64 | 2.94 | (0.96) | (0.14) | (0.03) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
0.11 | 0.11 | (0.06) | 0.64 | 2.94 | (0.96) | (0.14) | (0.03) | — |
Free Cash Flow |
(46.68) | (44.79) | (33.04) | (30.59) | (18.53) | (5.63) | (2.36) | (0.11) | — |
Working Capital |
8.89 | 1.62 | (7.31) | 15.93 | 53.04 | (14.27) | (5.95) | (1.06) | — |
Capital Expenditures |
(0.20) | (0.65) | (0.22) | (0.91) | (0.86) | — | — | — | — |
Net Current Asset Value |
7.96 | (0.18) | (7.51) | 14.89 | 53.04 | (14.27) | (5.95) | (1.06) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Capex to Sales |
0.04 | 0.15 | 0.09 | 2.41 | 1.72 | — | — | — | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
1.08 | 1.10 | 1.87 | 1.22 | 0.00 | — | — | — | — |
Cash ROIC |
(67.03%) | (96.63%) | (108.20%) | (65.82%) | (17.09%) | 41.99% | 45.83% | 10.88% | — |
Accounts Receivable Turnover |
13.68 | 96.58 | 78.32 | 3.47 | 0.00 | — | — | — | — |
Accounts Payable Turnover |
6.03 | 5.95 | 5.43 | 2.84 | 0.33 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
19.22 | 22.94 | 30.74 | 0.00 | 0.00 | — | — | — | — |
Average Days of Payables |
53.08 | 63.81 | 69.96 | 106.65 | 929.66 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
19.32 | 17.53 | 16.97 | 11.21 | 0.00 | — | — | — | — |
Average Receivables |
0.34 | 0.05 | 0.03 | 0.11 | — | — | — | — | — |
Average Payables |
1.11 | 1.19 | 1.10 | 1.27 | 1.77 | 1.43 | 0.65 | 0.65 | — |
Average Inventory |
0.35 | 0.31 | 0.19 | — | — | — | — | — | — |
Average Assets |
35.58 | 28.99 | 29.89 | 45.75 | 30.60 | 1.61 | 0.53 | 0.01 | — |
Average Common Equity |
(46.18) | (34.98) | 1.06 | 38.89 | 20.61 | (9.41) | (3.19) | (3.19) | — |
Columns are period end dates